184 related articles for article (PubMed ID: 29061059)
1. Bone metastases in neuroendocrine tumors.
Zamborsky R; Svec A; Kokavec M; Galbavy S
Bratisl Lek Listy; 2017; 118(9):529-534. PubMed ID: 29061059
[TBL] [Abstract][Full Text] [Related]
2. Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio State University Medical Center.
Kavecansky J; Wei L; Caronia L; Ramirez MT; Bloomston M; Shah MH
Pancreas; 2015 Mar; 44(2):198-203. PubMed ID: 25411805
[TBL] [Abstract][Full Text] [Related]
3. [Bone metastases in lung cancer].
Tsuya A; Fukuoka M
Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
[TBL] [Abstract][Full Text] [Related]
4. Metastatic bone disease in the era of bone-targeted therapy: clinical impact.
Ibrahim T; Farolfi A; Mercatali L; Ricci M; Amadori D
Tumori; 2013; 99(1):1-9. PubMed ID: 23548992
[TBL] [Abstract][Full Text] [Related]
5. The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses.
Saba N; Khuri F
Oncology; 2005; 68(1):18-22. PubMed ID: 15775689
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours.
Zheng GZ; Chang B; Lin FX; Xie D; Hu QX; Yu GY; Du SX; Li XD
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27430483
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases, general and clinical issues.
Greco C; Forte L; Erba P; Mariani G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):337-52. PubMed ID: 21738111
[TBL] [Abstract][Full Text] [Related]
8. [Encounter of cancer cells with bone. Therapy for bone metastasis from lung cancer].
Sugiura H
Clin Calcium; 2011 Mar; 21(3):439-45. PubMed ID: 21358066
[TBL] [Abstract][Full Text] [Related]
9. Metastatic bone disease and tumour-induced hypercalcaemia: treatment options.
Heatley S
Int J Palliat Nurs; 2004 Jan; 10(1):41-6. PubMed ID: 14966444
[TBL] [Abstract][Full Text] [Related]
10. [Management of bone metastases].
Nagykálnai T; Landherr L
Orv Hetil; 2014 Feb; 155(6):217-25. PubMed ID: 24486845
[TBL] [Abstract][Full Text] [Related]
11. Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.
Duran I; Fink MG; Bahl A; Hoefeler H; Mahmood A; Lüftner D; Ghazal H; Wei R; Chung KC; Hechmati G; Green J; Atchison C
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 26865392
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment options of neuroendocrine tumours].
Uhlyarik A; Pápai Z
Orv Hetil; 2013 Sep; 154(39):1549-55. PubMed ID: 24058100
[TBL] [Abstract][Full Text] [Related]
13. [The incidence and management of bone metastasis from breast cancer].
Saeki T; Ookubo K; Takeuchi H; Fujiuchi N
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1054-7. PubMed ID: 16912520
[TBL] [Abstract][Full Text] [Related]
14. Managing metastatic bone pain: New perspectives, different solutions.
Zaporowska-Stachowiak I; Łuczak J; Hoffmann K; Stachowiak K; Bryl W; Sopata M
Biomed Pharmacother; 2017 Sep; 93():1277-1284. PubMed ID: 28747002
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches for protecting bone health in patients with breast cancer.
Lüftner D; Niepel D; Steger GG
Breast; 2018 Feb; 37():28-35. PubMed ID: 29073497
[TBL] [Abstract][Full Text] [Related]
16. [Carcinoid tumors].
Pregun I; Bodoky G; Rácz K; Tulassay Z
Orv Hetil; 2010 Nov; 151(46):1885-94. PubMed ID: 21044939
[TBL] [Abstract][Full Text] [Related]
17. Management of bone metastases in cancer: a review.
Selvaggi G; Scagliotti GV
Crit Rev Oncol Hematol; 2005 Dec; 56(3):365-78. PubMed ID: 15978828
[TBL] [Abstract][Full Text] [Related]
18. [Role of bone-density-conserving agents in the treatment for pain in patients with bone metastases].
Zhabina AS; Semiglazova TY
Vopr Onkol; 2015; 61(2):303-10. PubMed ID: 26087615
[TBL] [Abstract][Full Text] [Related]
19. Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
Lim KHJ; Raja H; D'Arienzo P; Barriuso J; McNamara MG; Hubner RA; Mansoor W; Valle JW; Lamarca A
Neuroendocrinology; 2020; 110(7-8):688-696. PubMed ID: 31639796
[TBL] [Abstract][Full Text] [Related]
20. The prognosis and management of neuroendocrine neoplasms-related metastatic bone disease: lessons from clinical practice.
Alexandraki KI; Pizanias M; Uri I; Thomas D; Page T; Kolomodi D; Low CS; Adesanya O; Tsoli M; Gross DJ; Randeva H; Srirajaskanthan R; Grozinsky-Glasberg S; Kaltsas G; Weickert MO
Endocrine; 2019 Jun; 64(3):690-701. PubMed ID: 30635793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
